盘点:11月Nature杂志精选文章一览(TOP 10)

2016-11-29 MedSci MedSci原创

【1】Nature:新发现 胰腺癌“大爆炸”基因突变转基因小鼠模型是分析基因功能的理想途径,为人们揭示了许多胰腺癌发展的基础信息。不过,建立转基因小鼠模型需要的时间比较长。慕尼黑工业大学的研究团队建立了基于转染的CRISPR/Cas9递送体系,该体系可以对胰腺基因组进行快速有效的多重编辑,以便全面理解胰腺癌的发展机制。这项研究发表在二月二十六日的Nature Communications杂志上

【1】Nature:新发现 胰腺癌“大爆炸”基因突变

转基因小鼠模型是分析基因功能的理想途径,为人们揭示了许多胰腺癌发展的基础信息。不过,建立转基因小鼠模型需要的时间比较长。慕尼黑工业大学的研究团队建立了基于转染的CRISPR/Cas9递送体系,该体系可以对胰腺基因组进行快速有效的多重编辑,以便全面理解胰腺癌的发展机制。这项研究发表在二月二十六日的Nature Communications杂志上。

免疫疗法对特定类型的癌症有很好的疗效,特别是肺癌和黑色素瘤。不过,迄今为止免疫疗法还无法攻克胰腺癌。华盛顿大学的研究人员最近在这方面取得了突破。他们在Nature Medicine杂志上发表文章,证实免疫疗法结合FAK抑制剂可以有效对抗胰腺癌。

科学家们发现胰腺癌与肿瘤微环境的交流,会削弱它们抵御溶瘤病毒的能力。Nature Medicine杂志发表的一项研究指出,胰腺癌与其支持细胞的互作会让它们在溶瘤病毒面前更加脆弱。而溶瘤病毒有望成为治疗胰腺癌的新希望。(文章详见--Nature:新发现 胰腺癌“大爆炸”基因突变

【2】Nature:著名遗传学家发表lncRNA重要发现

长非编码RNA(lncRNA)是一些长度超过二百个核苷酸的RNA分子,来自于基因组的非编码区域。虽然lncRNA没有编码任何蛋白质,但它们在不同组织和发育阶段的表达依然具有特异性,这说明lncRNA具有重要的生物学意义。在测序技术的帮助下,人们已经发现了数千种lncRNA,但这些lncRNA的生物学功能依然还是个谜。

人们发现,有些lncRNA通过RNA-蛋白互作招募调控复合物,进而影响附近基因的表达。可能正是因为这个原因,lncRNA表达往往与附近基因的表达相关。不过,这种关联分析起来并不容易。Broad研究所的科学家们最近在这方面取得了重要成果。他们在Nature杂志上发表文章揭示了lncRNA对基因表达的本地调控机制。文章通讯作者是著名遗传学家、美国科学院院士Eric S. Lander教授。Lander教授是Broad研究所的创始人,也是人类基因组计划主要负责人之一。

研究人员对小鼠细胞系进行基因操纵,分析了十二个生产lncRNA的基因组位点。研究显示,其中五个位点顺式影响附近基因的表达。值得注意的是,这些影响不需要lncRNA转录本本身,而是与lncRNA生产过程有关,比如启动子活性、转录过程和转录本剪接。

进一步研究表明,蛋白编码位点也能影响附近基因的表达。六个蛋白编码位点中有四个会对附近基因产生影响。这说明相邻基因的交流是一种普遍现象,涉及多种机制和顺式调控信号。(文章详见--Nature:著名遗传学家发表lncRNA重要发现

【3】Nature:重大突破!科学家发现低氧环境或许会诱发心脏再生!

近日一项刊登于Nature杂志上的研究报告中,来自西南医学中心的研究人员通过研究发现,将小鼠置于极端缺氧的环境中时小鼠也能够进行心肌再生。

文章中,研究者将小鼠生存环境中所呼吸的氧气的比例逐渐降低到7%(相当于珠穆朗玛峰山顶的氧气浓度),当小鼠在低氧环境中生存两周后,其机体的心肌细胞开始发生分裂和生长了,正常情况下在成体哺乳动物中心肌细胞并不能够进行分裂。此前研究者通过研究发现,新生哺乳动物的心脏有能力再生,这就类似于皮肤在损伤后能够自我修复一样,但随着动物年龄增长,在接下来的数周内,动物机体的心肌再生能力就会失去,也就是说心肌细胞必须“沐浴”在心脏种的富氧环境中。

研究者Hesham Sadek教授说道,成年人的心脏在心脏病发作后并没有能力进行任何深度修复,这也就是为何心脏病发作对机体会产生永久性的影响,虽然有悖常理,本文研究中研究者发现,明显降低氧气的暴露或许会避开因氧气而引发的细胞损伤,从而就会开启细胞的分裂模式,导致心脏再度生长。(文章详见--Nature:重大突破!科学家发现低氧环境或许会诱发心脏再生!

【4】Nature:糖尿病的炎症起因被发现

炎症是糖尿病患者发生心脏病、中风、肾脏疾病及其他相关并发症的主要原因之一。现在华盛顿大学医学院的研究人员发现了慢性炎症的一个可能的触发因素。

饮食中脂肪含量太高会通过刺激慢性炎症促进胰岛素抵抗。但是研究人员发现当某些免疫细胞不再生成脂肪酸,即使是在高脂饮食的喂养下,小鼠也不会发展为糖尿病并且不会出现慢性炎症。

相关研究结果在线发表在国际学术期刊Nature上。

研究人员表示,虽然我们取得的一些医学进展已经让糖尿病患者发生心脏病和中风的风险下降,但是那些接受了最佳治疗的病人仍然可能死于慢性炎症诱发的并发症,一些免疫细胞参与了慢性炎症的发生。

研究人员构建了在巨噬细胞中敲除脂肪酸合成酶(FAS)基因的小鼠模型,缺少了脂肪酸合成酶小鼠就无法合成脂肪酸。结果他们发现这样的小鼠不会出现饮食诱导的胰岛素抵抗和糖尿病,而对正常对照小鼠来说,高脂饮食通常会诱导胰岛素抵抗和糖尿病的发生。(文章详见--Nature:糖尿病的炎症起因被发现

【5】Nature:治疗实体瘤有了明确靶标,肿瘤干细胞确实存在

Nature上11月2日在线刊登的一篇文章从单细胞水平分析脑瘤基因组的研究文章显示癌症干细胞促进少突胶质细胞瘤的生长。这是一种生长缓慢但无法治愈的脑瘤。麻省总院和MIT的Broad研究所以及哈佛的研究人员合作,首次在人脑肿瘤样本中鉴定出肿瘤干细胞和其分化的子代。

通讯作者,麻省总院病理科的Mario Suvà大夫说:“我们的工作有力地支持了肿瘤干细胞是肿瘤增长的主要来源,因此,应考虑将其作为治疗的靶点。”

Suvà大夫说:“这项研究发现了肿瘤内不同的细胞分干细胞和分化的肿瘤细胞两大类别,表现出同样的发育模式。这是支持肿瘤干细胞模型的关键。试图了解尽可能多的肿瘤组织的遗传与非遗传决定因素让我们可以了解肿瘤的扩散,是设计新疗法的关键。我们的工作表明,针对一个特定的干细胞表型,例如免疫疗法,可能对少突胶质细胞瘤的患者有益。”(文章详见--Nature:治疗实体瘤有了明确靶标,肿瘤干细胞确实存在

【6】Nature:CRISPR治疗镰刀形细胞贫血症临床前试验成功

斯坦福大学医学院的研究团队利用CRISPR技术,在人体干细胞中修复了造成镰状细胞贫血病的基因,这些干细胞可以正常移植到小鼠体内并蓬勃发育。关于这项临床前试验成功的研究文章于11月7日在线发表在Nature上。

异常形状的红细胞(紫红色)是镰刀型细胞贫血症的特征之一

镰刀形细胞贫血症是一种隐性基因遗传病:患病者的血液红细胞表现为镰刀状,其携带氧的功能只有正常红细胞的一半。迄今为止还没有能真正治愈的药物。目前唯一批准用于治疗镰状细胞疾病的药物是hydroxyurea(羟基脲),该药物只能用来缓解症状,并不能治愈该疾病。

斯坦福大学医学院的研究团队利用CRISPR基因编辑技术,在人体干细胞中修复了造成镰状细胞贫血病的基因,这是在研发针对该疾病的基因治疗道路上走出的关键一步。这项最新研究证明了修复后的细胞能生成正常功能的血红蛋白分子,可以在正常红细胞中携带氧气,这些干细胞也可以正常移植回小鼠体内。

这项研究表明针对血源性遗传疾病,可以进行基因治疗修复,这是一种概念证明。这一研究成果于11月7日在线发表在Nature上。文章通讯作者是斯坦福大学医学院教授、CRISPR Therapeutics公司创始人Matthew Porteus 博士。(文章详见--Nature:CRISPR治疗镰刀形细胞贫血症临床前试验成功

【7】Nature:克服癌症免疫疗法耐药性的新策略

11月8日在Nature发表的一项研究中,Merghoub和他的团队用小鼠肿瘤模型表明,TAMCs的影响可以通过一种适当的靶向治疗而得以逆转。  

为了表明TAMCs确实参与了检查点阻断疗法的耐药性,研究人员使用一种特殊的生长促进剂,来增加它们在黑色素瘤中的数量,以制备一个适合他们研究的模型。他们发现,这使得肿瘤不太易受到检查点阻断疗法的影响。  

在TAMCs和检查点抑制剂耐药性之间建立了一种联系之后,研究人员下一步准备测试一个假说:阻断免疫抑制细胞的活性,可提高免疫疗法的反应。为此,他们使用了Infinity Pharmaceuticals生产的一种实验性药物,被称为IPI-549。这种药物可供临床使用,可阻断抑制细胞中的一个分子,称为PI3Kγ。阻断这种分子,改变了这些免疫抑制细胞的平衡,有利于更多的免疫激活。  

这些结果表明,TAMCs可促进检查点抑制剂的耐药性,IPI-549能选择性地阻断这些细胞,从而克服它们的抵抗力。  (文章详见--Nature:克服癌症免疫疗法耐药性的新策略)

【8】Nature:中国科学家发现1445种新RNA病毒

11月24日,Nature期刊在线发表了中国疾病控制中心传染病所研究员张永振团队主导、悉尼大学若干研究员参与的学术论文《无脊椎动物RNA病毒圈的重新界定》(Redefining the invertebrate RNA virosphere)。

在文章中,科学家自2011年起针对9个动物门、超过220种无脊椎动物标本进行了宏转录组测序,后者是以特定样品中微生物群落的全部RNA为研究对象,从转录水平上分析微生物群落中活跃菌种的组成及其相关情况;并发现:RNA病毒在无脊椎动物中普遍存在,多样性远超过现有病毒知识体系;RNA病毒和宿主关系复杂,既有频繁的跨物种传播,又有共同进化的特征。

据悉,病毒被学界称为“生命科学的暗物质”,在已知生物中基因组多样性最强、变异速度最高。(文章详见--Nature:中国科学家发现1445种新RNA病毒)

【9】Nature:终于知道减肥后体重不断反弹的原因了,与肠道微生物有关!

每年大约4500万美国人试图靠节食来减肥,但很少能长期维持。近日发表于Nature的一项新研究中,研究人员揭示了肠道微生物可能在节食后体重反弹中起着至关重要的作用,而且他们已经找到了可能阻止这种情况发生的方法。

研究人员使用了反复肥胖的小鼠模型进行研究,通过饲喂大量脂肪,然后正常饮食,并重复来引起小鼠体重减轻与增加。

研究人员发现改变了的肠道微生物可减少对节食反应的两种黄酮类化合物(芹黄素和柚皮素)的水平,而这两种黄酮类化合物是对健康大有益处的植物化合物。

另外,研究人员发现黄酮类化合物的减少干扰UCP-1 - a基因的表达,而这种基因在能量消耗或卡路里大量燃烧中发挥着作用。研究者猜测,可能这个过程导致体重反复增加。

研究人员认为他们的结果提示一种“后生物”治疗法,通过补充因节食丢失的黄酮类化合物,可能会有效对抗节食后体重反弹。这种策略已证实在小鼠中有效,但还需要进一步研究确定这种策略是否对人类有效。

总而言之,该研究结果发现了促进节食后体重反弹的可能的微生物因素,且表明以微生物为靶向的疗法可能有助于诊断和治疗这种常见病。(文章详见--Nature:终于知道减肥后体重不断反弹的原因了,与肠道微生物有关!

【10】Cell,Nature接连两篇文章再辩:癌症“坏运气”vs.环境因素

近期,Nature杂志发表论文:Tissue-specific mutation accumulation in human adult stem cells during life。来自欧洲的研究人员发现人类干细胞的DNA会以相对恒定的速度出错,无论是哪种器官,无论它们发生癌变的癌症类型是什么。这一研究为癌症内在因素和外在因素的争论提出了新的观点,也为不同器官中癌症发生率的不同提出了新的解释。

他们分析了31种人体组织癌变的数据,发现其中22种癌症可用干细胞分裂时“运气差”来解释,包括胰腺癌、骨癌、卵巢癌和脑癌。研究表明,人类组织内正常干细胞的分裂数与该组织癌症发生率之间的相关性达0.804,即高度相关。根据研究人员新开发的一个统计模型,组织的癌症发生率是这一相关性的平方,以百分比的形式表达就是65%。

研究表明,细胞分裂过程中的突变很少累积到生成癌症的点,即便是在细胞分裂速度相对高的组织中。研究小组发现在几乎所有病例中,都需要暴露于致癌物或其他环境因素来触发疾病。(文章详见--Cell,Nature接连两篇文章再辩:癌症“坏运气”vs.环境因素


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2017-02-28 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-12-03 现在

    学习中…………

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-12-02 1e19acbam91(暂无匿称)

    希望能给临床带来更多帮助

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-12-01 现在

    学习中……

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-11-30 gospel007

    最新的医学前沿,好。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-11-30 shqm0324

    ok

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-11-30 1e184d7bm65(暂无匿称)

    非常棒,对我帮助很大。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-11-30 雾夜芭蕾

    黑色素瘤的恶性程度依旧很高

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-11-30 后宫三千

    好的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1881470, encodeId=350c18814e03c, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Feb 28 15:49:00 CST 2017, time=2017-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159873, encodeId=be2a1598e318, content=学习中…………, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Sat Dec 03 08:37:27 CST 2016, time=2016-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159622, encodeId=628e159622cd, content=希望能给临床带来更多帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D61B4B08EB5084.jpg, createdBy=89f71988067, createdName=1e19acbam91(暂无匿称), createdTime=Fri Dec 02 09:24:01 CST 2016, time=2016-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159326, encodeId=0acf1593261b, content=学习中……, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161126/IMG5838DBFDE7ED75013.jpg, createdBy=01ac1975851, createdName=现在, createdTime=Thu Dec 01 08:55:28 CST 2016, time=2016-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159192, encodeId=6b4f159192c9, content=最新的医学前沿,好。, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b2a1732571, createdName= gospel007, createdTime=Wed Nov 30 15:41:59 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159121, encodeId=bd49159121c6, content=ok, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a46182675, createdName=shqm0324, createdTime=Wed Nov 30 09:04:21 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159116, encodeId=5f5515911653, content=非常棒,对我帮助很大。, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76491981781, createdName=1e184d7bm65(暂无匿称), createdTime=Wed Nov 30 09:01:16 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159098, encodeId=199f1590987b, content=黑色素瘤的恶性程度依旧很高, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLBkyaelI9ia3n9SbuKmBdaY0PqCOzd0nhRUstroXmUmXZ5EBTmibtLEvCCIpyHAqxQXGfZz49ibrwjkg/0, createdBy=39781652829, createdName=雾夜芭蕾, createdTime=Wed Nov 30 08:29:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159095, encodeId=7fdc15909577, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161008/IMG57F86839881C22340.jpg, createdBy=38251962317, createdName=后宫三千, createdTime=Wed Nov 30 08:05:01 CST 2016, time=2016-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=159062, encodeId=41bb159062b9, content=又学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161129/IMG583D776080D783812.jpg, createdBy=a3221980678, createdName=三十七画, createdTime=Wed Nov 30 07:00:44 CST 2016, time=2016-11-30, status=1, ipAttribution=)]
    2016-11-30 三十七画

    又学习了

    0

相关资讯

Nature杂志发布肺癌专题

肺癌是造成癌症死亡的主要原因,主要分为小细胞肺癌(15%)和非小细胞肺癌两大类,其中非小细胞肺癌又可分为腺癌(40%)、鳞状细胞癌(30%)和大细胞癌(15%)。不同类型的肺癌,治疗策略和预后情况也不尽相同。 十几年来肺癌发病率在中国攀升得很快,这主要是因为吸烟人数快速增加(大多是男性),据统计每天约有三***死于吸烟。本期Nature杂志发布了肺癌专题,以九篇文章的形式全面介绍了肺癌的诊

Nature专题:乳腺癌

       每年全球超过130万名女性被诊断出患有乳腺癌,使之成为仅次于肺癌的第二大常见癌症形式。随着开展了对乳腺癌加强普及认识的努力和行动,比如红丝带行动,乳腺癌受到了各方的关注,从而针对这种癌症致病机理,病理特征,以及治疗方法的研究,也得到了不少资助,获得了许多重要的成果发现。     &n